Immunotherapy for Advanced Non-small Cell Lung Cancer:Research Progress and Perspectives
10.3971/j.issn.1000-8578.2024.24.0090
- VernacularTitle:晚期非小细胞肺癌免疫治疗:研究进展和展望
- Author:
Jingyi WANG
1
;
Yuling ZHONG
;
Lin WU
Author Information
1. 410013 长沙,湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院胸内二科
- Keywords:
Non-small cell lung cancer;
Immunotherapy;
Immune checkpoint inhibitors
- From:
Cancer Research on Prevention and Treatment
2024;51(6):409-418
- CountryChina
- Language:Chinese
-
Abstract:
Immunotherapy has changed the treatment landscape of advanced non-small cell lung cancer(NSCLC),showing great potential in the treatment of untreated and relapsed or refractory(R/R)patients.However,numerous issues that need further exploration remain with the wide application of immunotherapy.They include the exploration of biomarkers for efficacy prediction,the optimization of immunotherapy modalities,immune-related adverse effects,and the management of special populations.This review summarizes the progress of the research on immunotherapy for advanced NSCLC and discusses its challenges and future directions.
